NPTH Fundamental Analysis - NEUPATH HEALTH INC

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to NPTH. NPTH was compared to 14 industry peers in the Health Care Providers & Services industry. While NPTH seems to be doing ok healthwise, there are quite some concerns on its profitability. NPTH does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year NPTH has reported negative net income.

NPTH had a positive operating cash flow in the past year.

NPTH had negative earnings in each of the past 5 years.

Of the past 5 years NPTH 4 years had a positive operating cash flow.

1.2 Ratios

NPTH's Return On Assets of -1.83% is in line compared to the rest of the industry. NPTH outperforms 50.00% of its industry peers.

Looking at the Return On Equity, with a value of -3.75%, NPTH is in line with its industry, outperforming 57.14% of the companies in the same industry.

The Return On Invested Capital of NPTH (4.40%) is better than 85.71% of its industry peers.

		Industry Rank	Sector Rank
ROA	-1.83%
ROE	-3.75%
ROIC	4.4%

ROA(3y)-3.74%

ROA(5y)-5.69%

ROE(3y)-7.64%

ROE(5y)-10.74%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Operating Margin value of 2.49%, NPTH perfoms like the industry average, outperforming 57.14% of the companies in the same industry.

Looking at the Gross Margin, with a value of 19.09%, NPTH is doing worse than 64.29% of the companies in the same industry.

In the last couple of years the Gross Margin of NPTH has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	2.49%
PM (TTM)	N/A
GM	19.09%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.42%

GM growth 5Y-1.04%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NPTH is destroying value.

Compared to 1 year ago, NPTH has about the same amount of shares outstanding.

Compared to 5 years ago, NPTH has more shares outstanding

Compared to 1 year ago, NPTH has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.81, we must say that NPTH is in the distress zone and has some risk of bankruptcy.

With a decent Altman-Z score value of 1.81, NPTH is doing good in the industry, outperforming 78.57% of the companies in the same industry.

NPTH has a debt to FCF ratio of 6.29. This is a slightly negative value and a sign of low solvency as NPTH would need 6.29 years to pay back of all of its debts.

NPTH's Debt to FCF ratio of 6.29 is fine compared to the rest of the industry. NPTH outperforms 64.29% of its industry peers.

NPTH has a Debt/Equity ratio of 0.50. This is a neutral value indicating NPTH is somewhat dependend on debt financing.

With an excellent Debt to Equity ratio value of 0.50, NPTH belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.5
Debt/FCF	6.29
Altman-Z	1.81

ROIC/WACC0.64

WACC6.91%

2.3 Liquidity

A Current Ratio of 1.20 indicates that NPTH should not have too much problems paying its short term obligations.

With an excellent Current ratio value of 1.20, NPTH belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.

A Quick Ratio of 1.20 indicates that NPTH should not have too much problems paying its short term obligations.

NPTH has a better Quick ratio (1.20) than 92.86% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.2
Quick Ratio	1.2

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for NPTH have decreased strongly by -928.57% in the last year.

NPTH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.65%.

The Revenue has been growing slightly by 7.96% on average over the past years.

EPS 1Y (TTM)-928.57%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-15.38%

Revenue 1Y (TTM)14.65%

Revenue growth 3Y6.16%

Revenue growth 5Y7.96%

Sales Q2Q%25.16%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y100%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year14.59%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

NPTH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NPTH is valued cheaply inside the industry as 92.86% of the companies are valued more expensively.

85.71% of the companies in the same industry are more expensive than NPTH, based on the Price/Free Cash Flow ratio.

		Industry Rank	Sector Rank
P/FCF	11.79
EV/EBITDA	7.31

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for NPTH!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

NEUPATH HEALTH INC

TSX-V:NPTH (11/27/2025, 7:00:00 PM)

0.41

+0.02 (+5.13%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)11-13 2025-11-13/bmo

Earnings (Next)03-25 2026-03-25

Inst Owners24.93%

Inst Owner ChangeN/A

Ins Owners2.02%

Ins Owner ChangeN/A

Market Cap23.05M

Revenue(TTM)79.41M

Net Income(TTM)-801.00K

Analysts80

Price Target0.51 (24.39%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)-100%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)1.03%

Revenue NY rev (1m)0%

Revenue NY rev (3m)6.03%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.29
P/FCF	11.79
P/OCF	8.85
P/B	1.08
P/tB	339.03
EV/EBITDA	7.31

EPS(TTM)-0.01

EYN/A

EPS(NY)0

Fwd EYN/A

FCF(TTM)0.03

FCFY8.48%

OCF(TTM)0.05

OCFY11.3%

SpS1.41

BVpS0.38

TBVpS0

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.83%
ROE	-3.75%
ROCE	6.11%
ROIC	4.4%
ROICexc	5%
ROICexgc	19.84%
OM	2.49%
PM (TTM)	N/A
GM	19.09%
FCFM	2.46%

ROA(3y)-3.74%

ROA(5y)-5.69%

ROE(3y)-7.64%

ROE(5y)-10.74%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.42%

GM growth 5Y-1.04%

F-Score5

Asset Turnover1.81

Health

		Industry Rank	Sector Rank
Debt/Equity	0.5
Debt/FCF	6.29
Debt/EBITDA	2.49
Cap/Depr	27.81%
Cap/Sales	0.82%
Interest Coverage	6.88
Cash Conversion	60.43%
Profit Quality	N/A
Current Ratio	1.2
Quick Ratio	1.2
Altman-Z	1.81

F-Score5

WACC6.91%

ROIC/WACC0.64

Cap/Depr(3y)39.19%

Cap/Depr(5y)26.48%

Cap/Sales(3y)1.5%

Cap/Sales(5y)1.05%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-928.57%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-15.38%

EPS Next Y100%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)14.65%

Revenue growth 3Y6.16%

Revenue growth 5Y7.96%

Sales Q2Q%25.16%

Revenue Next Year14.59%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y97.7%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year287.08%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-7.08%

FCF growth 3Y3.23%

FCF growth 5YN/A

OCF growth 1Y0%

OCF growth 3Y10.75%

OCF growth 5YN/A

NEUPATH HEALTH INC / NPTH.CA FAQ

Can you provide the ChartMill fundamental rating for NEUPATH HEALTH INC?

ChartMill assigns a fundamental rating of 3 / 10 to NPTH.CA.

What is the valuation status of NEUPATH HEALTH INC (NPTH.CA) stock?

ChartMill assigns a valuation rating of 2 / 10 to NEUPATH HEALTH INC (NPTH.CA). This can be considered as Overvalued.

What is the profitability of NPTH stock?

NEUPATH HEALTH INC (NPTH.CA) has a profitability rating of 3 / 10.

NEUPATH HEALTH INC (NPTH.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

NEUPATH HEALTH INC / NPTH.CA FAQ

Can you provide the ChartMill fundamental rating for NEUPATH HEALTH INC?

What is the valuation status of NEUPATH HEALTH INC (NPTH.CA) stock?

What is the profitability of NPTH stock?